Sciety

Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate

This article has 18 authors:
1. Kajal Arora
2. Ruchir Rastogi
3. Nupur Mehrotra Arora
4. Deepak Parashar
5. Jeny Paliwal
6. Aelia Naqvi
7. Apoorva Srivastava
8. Sudhir Kumar Singh
9. Sriganesh Kalyanaraman
10. Swaroop Potdar
11. Devanand Kumar
12. Vidya Bhushan Arya
13. Sarthi Bansal
14. Satabdi Rautray
15. Indrajeet Singh
16. Pankaj Surendra Fengade
17. Bibekanand Kumar
18. Prabuddha Kumar Kundu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 19, 2020Latest activity Jun 9, 2020
Binding of the SARS-CoV-2 spike protein to glycans

This article has 10 authors:
1. Wei Hao
2. Bo Ma
3. Ziheng Li
4. Xiaoyu Wang
5. Xiaopan Gao
6. Yaohao Li
7. Bo Qin
8. Shiying Shang
9. Sheng Cui
10. Zhongping Tan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 1, 2021Latest activity Jun 8, 2020
Architecture and self‐assembly of the SARS‐CoV ‐2 nucleocapsid protein

This article has 4 authors:
1. Qiaozhen Ye
2. Alan M. V. West
3. Steve Silletti
4. Kevin D. Corbett
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 6, 2020Latest activity Jun 8, 2020
Distinct conformational states of SARS-CoV-2 spike protein

This article has 9 authors:
1. Yongfei Cai
2. Jun Zhang
3. Tianshu Xiao
4. Hanqin Peng
5. Sarah M. Sterling
6. Richard M. Walsh
7. Shaun Rawson
8. Sophia Rits-Volloch
9. Bing Chen
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 17, 2020Latest activity Jun 8, 2020
Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase

This article has 13 authors:
1. A. Shannon
2. B. Selisko
3. NTT Le
4. J. Huchting
5. F. Touret
6. G. Piorkowski
7. V. Fattorini
8. F. Ferron
9. E. Decroly
10. C Meier
11. B. Coutard
12. O. Peersen
13. B. Canard
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 15, 2020Latest activity Jun 8, 2020
Structure of SARS-CoV-2 main protease in the apo state reveals the inactive conformation

This article has 15 authors:
1. Xuelan Zhou
2. Fangling Zhong
3. Cheng Lin
4. Xiaohui Hu
5. Yan Zhang
6. Bing Xiong
7. Xiushan Yin
8. Jinheng Fu
9. Wei He
10. Jingjing Duan
11. Yang Fu
12. Huan Zhou
13. Qisheng Wang
14. Jian Li
15. Jin Zhang
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 13, 2020Latest activity Jun 8, 2020
The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase

This article has 13 authors:
1. Yousef M.O. Alhammad
2. Maithri M. Kashipathy
3. Anuradha Roy
4. Jean-Philippe Gagné
5. Peter McDonald
6. Philip Gao
7. Louis Nonfoux
8. Kevin P. Battaile
9. David K. Johnson
10. Erik D. Holmstrom
11. Guy G. Poirier
12. Scott Lovell
13. Anthony R. Fehr
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 12, 2020Latest activity Jun 8, 2020
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2

This article has 8 authors:
1. Lin Liu
2. Pradeep Chopra
3. Xiuru Li
4. Kim M. Bouwman
5. S. Mark Tompkins
6. Margreet A. Wolfert
7. Robert P. de Vries
8. Geert-Jan Boons
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 2, 2021Latest activity Jun 7, 2020
A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability

This article has 24 authors:
1. Xiangyang Chi
2. Renhong Yan
3. Jun Zhang
4. Guanying Zhang
5. Yuanyuan Zhang
6. Meng Hao
7. Zhe Zhang
8. Pengfei Fan
9. Yunzhu Dong
10. Yilong Yang
11. Zhengshan Chen
12. Yingying Guo
13. Jinlong Zhang
14. Yaning Li
15. Xiaohong Song
16. Yi Chen
17. Lu Xia
18. Ling Fu
19. Lihua Hou
20. Junjie Xu
21. Changming Yu
22. Jianmin Li
23. Qiang Zhou
24. Wei Chen
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 8, 2020Latest activity Jun 7, 2020
Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19

This article has 13 authors:
1. Xiaohan Ren
2. Xiyi Wei
3. Guangyao Li
4. Shancheng Ren
5. Xinglin Chen
6. Tongtong Zhang
7. Xu Zhang
8. Zhongwen Lu
9. Zebing You
10. Shangqian Wang
11. Chao Qin
12. Ninghong Song
13. Zengjun Wang
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 8, 2020Latest activity Jun 7, 2020

Previous Page 33 of 92 Next

Biochemistry

Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate

Binding of the SARS-CoV-2 spike protein to glycans

Architecture and self‐assembly of the SARS‐CoV ‐2 nucleocapsid protein

Distinct conformational states of SARS-CoV-2 spike protein

Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase

Structure of SARS-CoV-2 main protease in the apo state reveals the inactive conformation

The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase

Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2

A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability

Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19